新型N,N-二尿素衍生物作为IDO1抑制剂的合成和活性研究
Xi-Xi Hou1, Zi-Yuan Wu1,2, An Zhan1,2
1Department of Pharmacy, The First Affiliated Hospital, and College of Clinical Medicine of Henan University of Science and Technology, Luoyang, China.
Frontiers in chemistry
|July 6, 2023
概括
研究人员开发了新的N,N-二尿素和三醇化合物,以抑制胺二二氧化酶1 (IDO1). 化合物3g显示出显著的IDO1抑制活性,为癌症免疫治疗药物开发提供了潜力.
科学领域:
- 药用化学 医学化学
- 癌症免疫疗法癌症免疫疗法
- 酶学 是一种酶学.
背景情况:
- 印度醇胺2,3-二氧化酶1 (IDO1) 是癌症中一个关键的免疫调节酶.
- IDO1在瘤免疫逃避中起着至关重要的作用.
- 准IDO1是癌症免疫治疗的一个有前途的策略.
研究的目的:
- 设计和合成新型化合物作为潜在的IDO1抑制剂.
- 评估合成化合物的体外酶活性与IDO1.1.相比.
- 为了研究具有 IDO1.1 的强效抑制剂的结合方式.
主要方法:
- 有机合成N,N-二尿素和三醇衍生物.
- 酶活性测定用于确定IDO1抑制.
- 分子对接模拟以分析联结体-蛋白相互作用.
主要成果:
- 一系列针对IDO1的新型化合物已成功合成.
- 化合物3g显示出强大的IDO1抑制活性,IC50为1.73±0.97μM.
- 分子对接提供了关于化合物3g与IDO1.1的结合相互作用的见解.
结论:
- 合成的化合物代表了一个有前途的新类IDO1抑制剂.
- 化合物3g是癌症免疫疗法进一步发展的主要候选者.
- 这项研究有助于开发针对各种癌症的IDO1的新型治疗剂.
相关概念视频
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
608
Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
608
Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
1.1K
Cholinergic agonists or cholinomimetics mimic the action of acetylcholine to stimulate the parasympathetic nervous system. They are categorized into direct-acting and indirect-acting agents. The direct-acting cholinergic drugs induce the parasympathetic response by directly binding to the muscarinic or nicotine receptors. In comparison, the indirect-acting cholinergic drugs prevent acetylcholine hydrolysis, indirectly contributing to the extended parasympathetic response.
The direct-acting...
The direct-acting...
1.1K
Dipeptidyl Peptidase 4 Inhibitors
214
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
214
ortho–para-Directing Activators: –CH3, –OH, –⁠NH2, –OCH3
6.1K
All ortho–para directors, excluding halogens, are activating groups. These groups donate electrons to the ring, making the ring carbons electron-rich. Consequently, the reactivity of the aromatic ring towards electrophilic substitution increases. For instance, the nitration of anisole is about 10,000 times faster than the nitration of benzene. The electron-donating effect of the methoxy group in anisole activates the ortho and para positions on the ring and stabilizes the corresponding...
6.1K
Adrenergic Agonists: Chemistry and Structure-Activity Relationship
3.1K
Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
3.1K


